Skip to main content
. 2014 May 16;15(5):8773–8794. doi: 10.3390/ijms15058773

Table 2.

Tumor cell survival after treatment of H3 melanoma brain metastasis cells. CDI, coefficient of drug interaction.

Concentration (M) Temsirolimus (% Survival) Vemurafenib (% Survival) Combined (% Survival) CDI
0 100 ± 4.7 100 ± 4.7 100 ± 4.7 -
0.05 87.6 ± 2.3 99.9 ± 6.5 85.6 ± 2.5 0.98
5 79.0 ± 3.4 64.0 ± 2.5 75.6 ± 4.3 1.50
10 79.8 ± 5.9 42.3 ± 1.2 46.8 ± 3.9 1.39